Jian‐Guo Hong

512 total citations
30 papers, 315 citations indexed

About

Jian‐Guo Hong is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Jian‐Guo Hong has authored 30 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Oncology and 10 papers in Hepatology. Recurrent topics in Jian‐Guo Hong's work include Liver Disease Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Jian‐Guo Hong is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Jian‐Guo Hong collaborates with scholars based in China, United States and Australia. Jian‐Guo Hong's co-authors include Tao Li, Zhao‐Ru Dong, Zhiqiang Chen, Lun‐Jie Yan, Zi‐Niu Ding, Hui Liu, Jun-Shuai Xue, Chuncheng Yang, Dongxu Wang and Bao‐Wen Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Medicine.

In The Last Decade

Jian‐Guo Hong

28 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Guo Hong China 11 158 93 85 52 52 30 315
D Majumdar United Kingdom 7 114 0.7× 75 0.8× 98 1.2× 82 1.6× 37 0.7× 20 298
Daan P. Livestro Netherlands 5 191 1.2× 55 0.6× 47 0.6× 44 0.8× 62 1.2× 6 328
Takumi Fujimura Japan 9 85 0.5× 63 0.7× 84 1.0× 108 2.1× 27 0.5× 26 361
Jiewen Peng China 10 206 1.3× 73 0.8× 45 0.5× 53 1.0× 35 0.7× 19 331
Ting‐Jung Wu Taiwan 11 94 0.6× 112 1.2× 165 1.9× 82 1.6× 20 0.4× 21 359
Haniee Chung United States 7 114 0.7× 49 0.5× 94 1.1× 63 1.2× 150 2.9× 14 383
Xavier Chopin‐Laly France 10 347 2.2× 165 1.8× 87 1.0× 66 1.3× 18 0.3× 13 498
Saïda Aarrass Netherlands 7 70 0.4× 44 0.5× 37 0.4× 88 1.7× 174 3.3× 14 368
Seijin Nadano Japan 9 114 0.7× 99 1.1× 109 1.3× 24 0.5× 33 0.6× 26 283
Šárka Svobodová Czechia 13 132 0.8× 42 0.5× 20 0.2× 75 1.4× 27 0.5× 27 299

Countries citing papers authored by Jian‐Guo Hong

Since Specialization
Citations

This map shows the geographic impact of Jian‐Guo Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Guo Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Guo Hong more than expected).

Fields of papers citing papers by Jian‐Guo Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Guo Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Guo Hong. The network helps show where Jian‐Guo Hong may publish in the future.

Co-authorship network of co-authors of Jian‐Guo Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Guo Hong. A scholar is included among the top collaborators of Jian‐Guo Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Guo Hong. Jian‐Guo Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Cheng‐Long, Bao‐Wen Tian, Chuncheng Yang, et al.. (2023). The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology. 17(2). 189–198. 3 indexed citations
2.
Long, Junyu, Dongxu Wang, Hui Liu, et al.. (2023). Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts. International Immunopharmacology. 126. 111281–111281. 2 indexed citations
3.
4.
Xue, Jun-Shuai, Hui Liu, Siyu Tan, et al.. (2023). Salvage surgery after combination immunotherapy for initially unresectable or metastastic hepatocellular carcinoma: A retrospective clinical study. SHILAP Revista de lepidopterología. 2(4). 100025–100025. 3 indexed citations
5.
Hong, Jian‐Guo, Lun‐Jie Yan, Xian Li, et al.. (2022). Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World Journal of Gastroenterology. 28(6). 689–692. 1 indexed citations
6.
Han, Cheng‐Long, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2022). The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 827788–827788. 27 indexed citations
7.
Tian, Bao‐Wen, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2022). Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis. International Immunopharmacology. 114. 109519–109519. 4 indexed citations
8.
Liu, Hui, et al.. (2022). Clinical benefits of direct‐acting antivirals therapy in hepatitis C virus patients with hepatocellular carcinoma: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 37(9). 1654–1665. 4 indexed citations
9.
Yan, Lun‐Jie, Zi‐Niu Ding, Jian‐Guo Hong, et al.. (2022). Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis. Journal of Clinical and Translational Hepatology. 10(5). 835–846. 4 indexed citations
10.
Ding, Zi‐Niu, Jun-Shuai Xue, Lun‐Jie Yan, et al.. (2022). Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis. Journal of Cancer Research and Clinical Oncology. 149(5). 1993–2008. 13 indexed citations
11.
Xue, Jun-Shuai, Zi‐Niu Ding, Lun‐Jie Yan, et al.. (2022). The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 872353–872353. 13 indexed citations
12.
13.
Xue, Jun-Shuai, Hui Liu, Zi‐Niu Ding, et al.. (2021). Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis. Cancer Immunology Immunotherapy. 71(7). 1633–1644. 11 indexed citations
14.
Yan, Lun‐Jie, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2021). Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Hepatology International. 15(6). 1413–1420. 9 indexed citations
15.
Yan, Yu‐Chuan, Zi‐Niu Ding, Yanfeng Liu, et al.. (2021). Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies. Journal of Cancer. 13(1). 88–101. 10 indexed citations
16.
Ding, Zi‐Niu, Zhao‐Ru Dong, Zhiqiang Chen, et al.. (2021). Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis. Frontiers in Immunology. 12. 733530–733530. 26 indexed citations
17.
Li, Zhen, Kangyu Wang, & Jian‐Guo Hong. (2018). Rare Multiple Lesions Arising in Small and Large Intestines. Gastroenterology. 156(5). e1–e3. 1 indexed citations
18.
Zhi, Xu–Ting, Jian‐Guo Hong, Tao Li, et al.. (2017). Gastric Crohn's Disease: A Rare Cause of Intermittent Abdominal Pain and Vomiting. The American Journal of Medicine. 130(5). e181–e185. 5 indexed citations
19.
Li, Tao, et al.. (2016). Calcified Cystic Lesion of the Pancreas. Journal of Gastrointestinal Surgery. 20(6). 1272–1274. 3 indexed citations
20.
Wang, Jian, Jingjing Wu, Jian‐Guo Hong, et al.. (2011). PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6. Cancer Letters. 311(1). 38–47. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Majumdar Breakdown of academic impact, for papers by Daan P. Livestro Breakdown of academic impact, for papers by Takumi Fujimura Breakdown of academic impact, for papers by Jiewen Peng Breakdown of academic impact, for papers by Ting‐Jung Wu Breakdown of academic impact, for papers by Haniee Chung Breakdown of academic impact, for papers by Xavier Chopin‐Laly Breakdown of academic impact, for papers by Saïda Aarrass Breakdown of academic impact, for papers by Seijin Nadano Breakdown of academic impact, for papers by Šárka Svobodová
Rankless by CCL
2026